Edition:
United States

ICAD Inc (ICAD.OQ)

ICAD.OQ on NASDAQ Stock Exchange Capital Market

3.28USD
21 Feb 2018
Change (% chg)

-- (--)
Prev Close
$3.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,264
52-wk High
$6.01
52-wk Low
$2.93

Chart for

About

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments:... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $54.09
Shares Outstanding(Mil.): 16.44
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 16.11 16.73
EPS (TTM): -- -- --
ROI: -- 11.28 35.60
ROE: -- 21.07 17.23

BRIEF-iCAD Expects To Reduce About 18 Pct Of Workforce Across Skin Subscription Business

* ICAD INC SAYS CO EXPECTS TO REDUCE HEADCOUNT ACROSS SKIN SUBSCRIPTION BUSINESS BY ABOUT 21 EMPLOYEES OR 18% OF THE WORKFORCE- SEC FILING

Jan 05 2018

BRIEF-ICAD reports Q3 GAAP loss per share $0.42

* Q3 revenue rose 17 percent to $7.0 million Source text for Eikon: Further company coverage:

Nov 08 2017

BRIEF-ICAD Inc ‍announces approval of Xoft Axxent balloon applicators by China FDA

* ICAD Inc - ‍announces approval of Xoft Axxent balloon applicators by China Food & Drug Administration for treatment of early-stage breast cancer​ Source text for Eikon: Further company coverage:

Aug 30 2017

Earnings vs. Estimates